A new American Heart Association (AHA) scientific statement focuses on the evidence for and implementation of lipoprotein apheresis, an emerging treatment
Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Associationdoi:10.1161/ATV.0000000000000177AHA Scientific Statementsblood component removalcardiovascular diseasescholesterol, LDL...
It provides guidance on screening, risk assessment, and treatment recommendations for a range of patients with various lipid disorders. These recommendations emphasize the importance of treating low-density lipoprotein cholesterol (LDL-C) in some individuals to lower goals than previously recommended and ...
Reduced plasma concentrations of high-density lipoprotein cholesterol (HDL-C) are a risk factor for coronary artery disease (CAD). In this study, we examined the sequential effects of an isocaloric American Heart Association (AHA) step I diet and a hypocaloric AHA step I diet (AHA step I ...
M. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 15, 158–161. https://doi.org/10.1016/j.tcm.2005.05.008 (2005). Article CAS PubMed Google Scholar Després, J. P. Intra-abdominal obesity: an untreated risk factor for type 2 diabetes and cardiovascular ...
This was the first trial to demonstrate incremental clinical benefit by adding a nonstatin agent to statin therapy and reaffirmed the low-density lipoprotein (LDL) hypothesis stating that reducing LDL-cholesterol prevents CV events. Summaries and overviews of both the late-breaking trials and the ...
1 These risk estimates are calculated using a combination of CVD risk factors (age, sex, race/ethnicity, diabetes, smoking, systolic blood pressure, antihypertensive use, total cholesterol level, and high-density lipoprotein cholesterol level) that were examined in selected community-based epidemiologic...
期刊名称:《Circulation research: a journal of the American Heart Association》 | 2014年第4期 关键词: arginase; atherosclerosis; mitochondria; mitochondrial processing peptidase; nitric oxide synthase type III; oxidized low density lipoprotein; 28.Transgenic expression of dominant-active IDOL in liver...
Most of these patients had a low‐density lipoprotein cholesterol between 70 and 99mg/dL with no or a low‐intensity statin prescribed. Opportunities exist to improve cholesterol management in diabetes mellitus patients in community health centers. Addressing care gaps could improve cardiovascular ...
In this study, we examined the sequential effects of an isocaloric American Heart Association (AHA) step I diet and a hypocaloric AHA step I diet (AHA step I diet + weight loss) on lipoprotein lipid levels in 14 middle-aged and older (60 ± 6 years, mean ± SD) obese (body mass ...